Advancing Cost Competitive Thermal Energy Storage by Cutting on Site Costs Through Factory Built Design
TEL AVIV, IL / ACCESS Newswire / February 11, 2026 / Brenmiller Energy Ltd. (Nasdaq:BNRG) (the “Company”, “Brenmiller” or “Brenmiller Energy”), a leading provider of thermal energy storage (“TES”) solutions for industrial and utility applications, today announced the launch of bGen ONE™, a new system design that delivers on the Company’s previously disclosed Technology Roadmap 2030 and advances its aim to materially reduce the cost of industrial decarbonized heat.
In April 2025, Brenmiller outlined its roadmap to achieve significant performance gains at substantially lower cost across next generation thermal energy storage platforms, including the planned introduction of bGen ONE™. Today’s announcement reflects continued execution against that roadmap and is intended to support broader market adoption.
“This announcement is about execution,” said Avi Brenmiller, Chairman and Chief Executive Officer of Brenmiller Energy. “bGen ONE™ demonstrates that we are delivering on our roadmap by reducing installed cost and enabling TES to compete in industrial heat applications where natural gas remains the default.”
A New Design Built for Cost Reduction and Manufacturing Control
bGen ONE™ introduces a standardized, factory built architecture based on modular containerized units that are pre-fabricated and integrated at Brenmiller’s manufacturing facility. Key assembly work including module integration, piping, insulation, electrical systems and controls is shifted from the field into a controlled manufacturing environment to reduce on site cost and execution risk. This design is based on the existing bGen platform, utilizing the same proven bCube architecture, ensuring continuity with current deployments while enabling a more efficient and repeatable delivery model.
bGen ZERO™ installation at Tempo Picture: Brenmiller Energy bGen ONE™ illustration
This design approach is expected to:
• Reduce on site labor and construction scope by over 50%, materially lowering installed engineering, procurement, and construction (“EPC”) costs; • Shift approximately 25% of project scope traditionally executed by EPC contractors into Brenmiller’s manufacturing operations, supporting the potential for improved margins and revenue capture; • Increase control over quality, schedule, and execution through standardized manufacturing and repeatable delivery; • Enable more cost competitive offers for industrial customers seeking alternatives to fossil boilers; “We believe that launch of bGen ONE™ represents a shift from EPC heavy project delivery to a more product based execution model,” added Avi Brenmiller.
Strategic Focus on Small and Mid-Scale Industrial Heat
bGen ONE™ is designed for small and mid scale industrial heat users, a segment that represents a significant portion of global industrial activity and energy consumption and spans a wide range of manufacturing sectors. Decarbonization in this segment has been constrained primarily by cost competitiveness and project complexity rather than technology availability. By reducing installed cost and simplifying delivery, bGen ONE™ targets what the Company believes is a large, underserved market that requires standardized, product-based solutions rather than bespoke engineered projects.
Positioned for Local Manufacturing and Funding Driven Markets
bGen ONE™ is designed to support localized manufacturing strategies, enabling Brenmiller to participate in regional clean energy funding frameworks in markets such as the United States and the EU, where incentives increasingly favor domestically manufactured industrial decarbonization technologies.
Continuing Development of the Next bGen Generation
In line with its Technology Roadmap 2030, Brenmiller continues development of future TES generations targeting higher operating temperatures and improved efficiency, with enhanced economics resulting from these advancements, further strengthening the role of thermal energy storage as a scalable solution for global industrial decarbonization.
About Brenmiller Energy
Brenmiller Energy (NASDAQ:BNRG) provides TES solutions that enable industrial and utility customers to decarbonize heat, improve energy flexibility, and integrate renewable electricity. The Company’s bGen™ systems convert electricity into dispatchable industrial heat, supporting electrification and emissions reduction across a range of applications.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. Statements that are not statements of historical fact may be deemed to be forward-looking statements. For example, the Company is using forward-looking statements when discussing: expected reductions in on-site labor, EPC costs, and project complexity; anticipated benefits of factory-built and modular manufacturing; potential improvements in margins, revenue capture, and execution control; market adoption of bGen ONE™ and demand from small and mid-scale industrial customers; participation in local manufacturing and clean-energy funding frameworks; future development of next-generation thermal energy storage technologies; and the Company’s ability to execute on its Technology Roadmap 2030. Without limiting the generality of the foregoing, words such as “plan,” “project,” “potential,” “seek,” “may,” “will,” “expect,” “believe,” “anticipate,” “intend,” “could,” “estimate” or “continue” are intended to identify forward-looking statements. Readers are cautioned that certain important factors may affect the Company’s actual results and could cause such results to differ materially from any forward-looking statements that may be made in this press release. Factors that may affect the Company’s results include, but are not limited to: the Company’s planned level of revenues and capital expenditures; risks associated with the adequacy of existing cash resources; the demand for and market acceptance of our products; impact of competitive products and prices; product development, commercialization or technological difficulties; the success or failure of negotiations; trade, legal, social and economic risks; and political, economic and military instability in the Middle East, specifically in Israel. The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s Annual Report on Form 20-F for the year ended December 31, 2024 filed with the U.S. Securities and Exchange Commission (“SEC”) on March 4, 2025, which is available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
Tollo Health recently formed subsidiary TolloCare, LLC (‘TolloCare’) initially targeted to provide telehealth services for GLP-1 and Long COVID patients
TolloCare has white-labeled telehealth capabilities via a telemedicine company with over 5,000 onboarded physicians nationwide to provide synchronous and asynchronous medical services, including prescriptions, for weight loss and separately will cultivate a Long COVD physician base
Tollo Health has entered into agreement to expand TolloCare capabilities via a partnership with a stealth San Francisco Bay Area startup preparing to deploy a mental health AI app with unique tools to engage with patients
TAMPA, FLORIDA / ACCESS Newswire / February 11, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX), a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence (‘AI’) platform EinsteinRx™into its patented blockchain-enabled smart contracts platform PharmacyChain™, today announced that it has expanded its partnership Tollo Health, LLC (‘Tollo Health’). The partnership expansion includes the addition of telehealth services being developed by TolloCare, LLC (‘TolloCare‘), a wholly-owned subsidiary of Tollo Health, which focuses on telemedicine, an app-based mental health AI offering, and public health information. TolloCare was initially established to focus on GLP-1 and Long COVID patients and will now expand its focus to be able to service Wellgistics’ emerging partnership with NFL Alumni Health.
“More and more patients are interacting with their healthcare professionals primarily online,” said Prashant Patel, RPh, President & Interim-CEO of Wellgistics Health. “As we evolve our business model from pharmaceutical distribution-only to more comprehensively service patients both through our Wellgistics Pharmacy Network and our own online pharmacy, we understand that we must meet the patients where they are and provide convenient solutions that improve their outcomes. GLP-1 agonist drug use is becoming more widespread as more convenient as oral formulations begin to hit the market. Given that Forzet™ distribution is ready to begin this quarter, we believe now is the right time to expand into telemedicine. Tollo Health has positioned itself as an intellectual leader in understanding essential amino acid formulations and how they interplay with mitochondrial biology. It makes sense for us to leverage their intellectual capital to help to educate physicians and pharmacists on how best to use GLP-1 agonist drugs together with Forzet.”
Tollo Health recently formed TolloCare to expand into the telehealth space in order to pair GLP-1 and Long COVID patients with knowledgeable healthcare professionals who are educated on best practices in these two rapidly evolving areas. TolloCare recently expanded its telemedicine capabilities by way of a contracted services agreement with a market leading telehealth platform, and separately has entered into an agreement with a San Francisco Bay Area stealth app-based mental health artificial intelligence company to deploy unique tools across its patient base in order to help improve outcomes by supporting patients mental health and driving engagement. TolloCare intends to expand its focus into mental health, weight loss (maintaining weight loss after GLP-1 agonist drug discontinuation), cardiometabolic disease, sleep apnea, and pain management.
About Wellgistics Health, Inc.
Wellgistics Health (NASDAQ:WGRX) is a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence platform EinsteinRx™ into its patented blockchain-enabled smart contracts platform PharmacyChain™ to optimize the prescription drug dispending journey. Its integrated platform connects 6,500+ pharmacies (the “Wellgistics Pharmacy Network”) and 200+ manufacturers, offering wholesale distribution, digital prescription routing, direct-to-patient delivery, and AI-powered hub services such as eligibility, adherence, onboarding, prior authorization, and cash-pay fulfillment as needed to optimize patient access. Wellgistics provides end-to-end solutions designed to restore access, transparency, and trust in the U.S. prescription drug market for independent pharmacies.
This press release contains forward‑looking statements within the meaning of the federal securities laws, including, without limitation, statements regarding the parties’ plans to negotiate definitive agreements, potential implementation, adoption, performance, revenue sharing, and other anticipated benefits of the contemplated collaboration. These statements are subject to risks and uncertainties that could cause actual results to differ materially, including those described in DataVault AI, Inc.’s and Wellgistics Health, Inc.’s filings with the SEC. Forward‑looking statements speak only as of the date hereof, and neither company undertakes any obligation to update them except as required by law. Additional factors are discussed in Wellgistics Health’s filings with the SEC, available at www.sec.gov.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction, and there shall be no sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.
TORONTO, ON / ACCESS Newswire / February 11, 2026 / White Gold Corp. (TSXV:WGO)(OTCQX:WHGOF)(FRA:29W) (“White Gold” or the “Company“) is pleased to announce that it has commenced procedures for a spin-out transaction (the “Spin-Out”) to create a new, Yukon-focused critical minerals exploration company (“SpinCo”). The Spin-Out is designed to unlock the value of White Gold’s non-gold project portfolio by transferring its portfolio of copper, molybdenum, tungsten and other critical mineral properties located in west-central Yukon into a dedicated, standalone vehicle with shares to be distributed to shareholders. Included below is an overview of the Spin-Out and properties to be transferred to SpinCo. Additional details will be provided as the procedure continues to advance.
The proposed transaction will enable the Company to focus on advancing its flagship White Gold Project which hosts four near-surface gold deposits, that collectively contain an estimated 1,732,300 ounces of gold in indicated resources (35.2 million tonnes grading 1.53 grams per tonne gold) and 1,265,900 ounces of gold in inferred resources (32.2 million tonnes grading 1.22 g/t Au) (see the Company’s news release dated October 6, 2025), with significant expansion potential on the resource itself and in the immediately surrounding area, complimented by a substantial pipeline of gold targets across the Company’s district scale property portfolio. The Spin-Out will provide shareholders with direct exposure to a significant portfolio of critical mineral exploration projects prospective for copper, molybdenum, tungsten, silver, and other strategic metals to be efficiently advanced by a dedicated team and resources.
The Spin-Out portfolio includes several large-scale critical minerals targets prospective for Copper (Cu), Molybdenum (Mo), Tungsten (W), Antimony (Sb), Zinc (Zn) and Bismuth (Bi), underlain by highly prospective geology which were identified through White Gold’s data driven exploration methodologies which have proven to be successful in the region. Key targets – including the Bridget, Isaac, and Mascot – are situated within the Dawson Range, a prolific east-southeast trending mineral belt that hosts several significant copper-gold porphyry deposits including the Casino deposit (one of the largest undeveloped copper-gold projects in Canada), the Minto Mine, and the Carmacks Project.
“Over the past several years, White Gold has systematically built one of the most comprehensive regional geochemical and geological datasets in the Yukon, which has clearly highlighted the scale and quality of several copper and critical mineral targets within our portfolio in addition to our highly prospective gold projects. Assets such as Bridget, Isaac, and Wolf exhibit the size, metal zonation, and geophysical signatures typically associated with large, fertile porphyry systems, yet remain largely untested by drilling. Spinning these assets into a dedicated vehicle allows them to be advanced more effectively with the technical focus and disciplined exploration strategy they warrant,” commented Dylan Langille, Vice President of Exploration for White Gold Corp.
White Gold Corp’s CEO, David D’Onofrio stated, “The timing of this proposed spin-out aligns exceptionally well with the strong and growing support we are seeing from both the Yukon and federal governments for the responsible development of critical minerals. Recent initiatives focused on advancing critical mineral exploration, improving infrastructure, streamlining permitting, and strengthening collaboration across Western and Northern Canada reinforce Yukon’s position as a globally desirable jurisdiction for discovery and development. By creating a dedicated critical minerals company, we believe we are positioning these assets to directly benefit from this supportive policy environment, while providing shareholders with focused exposure to commodities that are increasingly central to Canada’s long-term economic and supply chain strategies.”
SpinCo Highlights:
Six properties representing approximately 15% of White Gold’s current claims which includes numerous copper and strategic metals targets (Cu, Mo, W, Sb, Zn, Bi) remain largely unevaluated and undrilled, presenting significant discovery upside.
Highly prospective geology for copper, molybdenum, tungsten, antimony and bismuth across multiple deposit styles.
District-scale exploration database covering the Company’s entire land package (Figure 1), including soil geochemical samples, and geophysical testing, have outlined multiple large, high-priority critical mineral anomalies.
Key targets – Bridget, Isaac and Mascot – situated within the Dawson Range, a proven mineral belt hosting major copper-gold systems such as the Casino deposit, Minto Mine, and the Carmacks Project.
The Bridget target, the most significant, untested porphyry system in the Company’s critical mineral portfolio, is comprised of a Mo-Cu porphyry anomaly covering a 3 x 3.5 km area enriched with tungsten, bismuth and silver and is transected by two large northwest trending major crustal-scale dextral transpressional faults. An initial technical report on this property will be filed in connection with the Spin-Out.
Several of the Spin-Out targets include additional upside potential for antimony and bismuth as secondary metals across orogenic gold, intrusion-related, epithermal, and porphyry systems.
Further details on the Spin-Out transaction to be provided as the process continues to advance with a near term anticipated completion, subject to shareholder and regulatory approvals.
Spin-Out of Critical Mineral Portfolio
The Spin-Out will be completed by way of a plan of arrangement under the Business Corporations Act (Ontario) and subject to the terms and conditions of an arrangement agreement (the “Arrangement Agreement“) to be entered into between the Company and SpinCo. Completion of the Spin-Out will also be conditional on the receipt of shareholder approval, and regulatory and court approvals, including, without limitation, the approval of the TSX Venture Exchange (the “TSXV“). It is intended that SpinCo will apply to list its shares on the TSXV and such listing will be subject to SpinCo fulfilling all of the requirements of the TSXV.
Additional details relating to the Spin-Out will be provided when the Company enters into the Arrangement Agreement. They will also be included in the management information circular in respect of the shareholders’ meeting to be held to consider and approve, among other things, the Spin-Out. Copies of the management information circular and related meeting materials will also be filed with the applicable Canadian securities regulators and will be available on SEDAR+ (www.sedarplus.ca).
Regional Setting – The Dawson Range and Critical Mineral Belt
The Dawson Range is an east-southeast trending mountain belt that hosts numerous significant mineral deposits and prospects along the Minto-Carmacks Copper Belt, including the Casino copper-gold porphyry deposit in the west owned by Western Copper and Gold (Figure 2). In the southeast near the community of Carmacks, the Minto Mine owned by Selkirk Copper Mines Inc. contains Indicated Resources of 12.588 Mt grading 1.203% Cu, 0.461 g/t Au, 1.728 thousand ounces Ag for 333.8 M lbs copper, 186.6 k oz gold, and 1.728 M ounces silver and Inferred Resources of 23.658 Mt grading 1.048 % Cu, 0.387 g/t Au, 3.9 g/t Ag for 546.8 M lbs copper, 294.7 K ounces gold, and 2.9681 K ounces silver(5)(2). It also hosts the Carmacks Copper project, which contains Measured and Indicated Resources of 36.25 Mt grading 0.81 % Cu, 3.25 g/t Ag, 0.26 g/t Au for 651 M lbs of copper, 3.79 M ounces silver, and 302 K ounces of gold(6)(2), owned by Cascadia Minerals Ltd. Both deposits are interpreted as metamorphosed copper-gold-silver porphyry systems. Porphyry deposits in the Dawson Range occur in two principal age groups: Late Triassic (e.g., Minto, Carmacks) and Late Cretaceous (e.g., Casino, Cash, Revenue). In addition to porphyry-style mineralization, the Dawson Range also hosts epithermal, skarn, and polymetallic to gold-dominant veins, breccias, and fracture zones (7). Owing to this diverse and highly prospective mineral endowment, the region has attracted increasing attention and investment in recent years from both junior and major mining companies.
Critical Minerals Portfolio Overview
The assets proposed to be transferred to SpinCo include six core properties that collectively represent a pipeline of advanced to early-stage critical mineral exploration opportunities across multiple prolific metallogenic belts in Yukon. Highlights include:
Bridget Property – Bridget Target
The Bridget target is a standout Mo-Cu porphyry anomaly with one of the highest molybdenum-in-soil signatures in the White Gold District, spanning a 3 x 3.5 km area and enriched with additional critical elements like tungsten, bismuth, and silver. It is transected by two large northwest trending major crustal-scale dextral transpressional faults – the Sixtymile River Fault and Big Creek Fault. Both faults host several significant multi-element porphyry and epithermal deposits. The target was initially identified in 1972 when Silver Standard Mines conducted an extensive 14,000-plus regional silt survey looking for another Casino deposit.
Geologically, the target is underlain by hornblende gneiss, biotite schists, and calc-silicate altered marble (skarn), intruded by quartz eye granite and aplite dikes. The soil geochemical footprint of the anomaly is characterized by Mo-in-soil values as high as 321.9 ppm Mo, including 278.9 ppm Mo, 265.4 ppm Mo, 263.5 ppm Mo, 257.2 ppm Mo, and 253.3 ppm Mo with over 400 additional samples returning values greater than 20 ppm Mo. Across the target, anomalous Cu-in-soil values exceeding 100 ppm Cu are common with the most significant enrichment occurring at the core with values as high as 710.1 ppm Cu, including 662.6 ppm Cu, 594.7 ppm Cu, 492.9 ppm Cu, 406 ppm Cu observed over a roughly 900 m x 900 m area. Other notably enriched critical minerals include tungsten (W), with the highest concentrations observed in the northern half of the target area, where soil sampling has yielded values up to 101 ppm W, with values exceeding 30 ppm W common. Other anomalous metals including Pb, Bi, As, Zn, and Ag are typically observed over two large northwest-southeast oriented fault systems which cut the target in the north and in the south. Two rounds of IP Geophysics performed in 2023 and 2025 have identified favourable subsurface chargeability and resistivity anomalies beneath the strong surface Cu-Mo-Zn-W soil geochemistry signatures.
The 2025 Bridget IP survey delineated multiple high-priority anomalies, including five porphyry targets defined by chargeability, resistivity, metal factor, and 2D inversion models. These geophysical features are directly associated with the large multi-element soil anomalies measuring 3 x 4.3 km. Together, these results represent strong evidence of the potential for concealed porphyry style mineralization system at Bridget.
Its size, multi-element enrichment, proximity to key structures, and lack of drilling make it the company’s most significant untested porphyry system and a critical priority for diamond drilling. An initial technical report on this property will be filed in connection with the Spin-Out.
Loonie Property – Guilder Target
Located adjacent to a known Cu-Au prospect (Lucky Joe), the Guilder target on the Loonie property hosts a 3 km long, northwest-southeast trending Cu-Mo-Au-Zn-Pb soil anomaly, which appears to be a northwestern extension of the Lucky Joe target. Prospecting on the Guilder target has uncovered malachite and chalcocite, hosted by quartz-feldspar-biotite schist, near an outcrop of augen gneiss. Samples from this showing returned 1114.8 ppm Cu and 6.1 g/t. Its proximity to historic mineralization and copper association makes it an attractive early-stage critical mineral target for follow-up work.
Wolf Property – Aries and Taurus Targets
The Aries target on Wolf property is an interpreted porphyry system that is characterized by a central zone of copper and molybdenum anomalies, surrounded by a large peripheral zone enriched in bismuth, arsenic, lead, and zinc. This forms a footprint measuring approximately 4 km in length (NE-SW) and 3 km in width (NW-SE). To the northeast, the Aries target transitions from a gold-dominant system into a potential porphyry system. This area’s molybdenum-in-soil values reach as high as 51.4 ppm, with the bulk of the anomaly showing values above 5 ppm. Copper-in-soil values peak at 923.9 ppm, with notable results such as 637.8 ppm, 630.8 ppm, and 600.6 ppm Cu, located near areas enriched in arsenic and bismuth. Previous drilling on the property has been gold-focused and the property remains largely untested and highly prospective for several critical minerals including Mo and Cu.
The Wolf property is located east of the White River, approximately 120 km south-southwest of Dawson City and 35 km west of the White Gold Project. Two main target areas have been identified on the property, the Aries and Taurus targets. The area is predominantly underlain by hornblende-biotite diorite intruded by medium-grained and megacrystic K-feldspar granites. These intrusions are associated with widespread biotite and potassic alteration, which are key indicators of potential porphyry mineralization.
To the north and northeast, the property is underlain by Late Cretaceous Carmacks volcanic units, including andesite and basalt flows, and siliciclastic basal conglomerates. Cu-Mo enrichment appears to be localized along the contact between these volcanic units and the adjacent granites while gold mineralization is concentrated in the southwestern part of the property (Taurus target) in shreddy biotite and k-spar altered hornblende-biotite diorites. The Taurus target features a gold-in-soil anomaly that spans approximately 2 km long by 0.5 km wide, with maximum gold values reaching 358 ppb Au. The anomaly has an arcuate shape, trending east-west in the southwest and curving northeast-southwest to the east. GT Probe bedrock sampling returned gold values up to 1.22 g/t Au, with several samples exceeding 0.5 g/t Au. In 2023 RAB drilling of the target returned gold values of up to 0.81 g/t Au over 15.24m from 19.81m (hole WLFTRS23RAB002) including 6.55 g/t Au over 1.52m, along with 0.32 g/t Au over 30.47m) from 13.72m in hole WLFTRS23RAB002.
Hunker Property – Bum, Mint, and Boxcar Targets
The Hunker Property includes historical high-grade Cu-Ag showings and a large Cu-Au soil anomaly at Mint Pup (2.5 km by 2.7km), with recent rock and soil samples showing strong copper values and porphyry-related alteration. It’s location in the Klondike goldfields and multiple Cu-Au showings make it a prime candidate for deeper exploration and geophysical targeting
Hayes Property – Isaac Target
The Isaac target measures approximately 2 km E-W by 1.5 km N-S with a central bismuth-arsenic enriched core measuring from 750 m to 1,000 m which is surrounded by a > 400 m wide halo of anomalous silver, lead and zinc. Anomalous copper occurs in the southern portion of the core, and a relatively small area of anomalous molybdenum occurs near the core’s northern margin. The target is located in the central part of the Hayes property 38 km east of the Casino deposit and is a geochemically zoned multi-element soil anomaly associated with a mapped unit of Late Cretaceous Prospector Mountain suite intrusive rocks. Anomalous copper-in-soils occurs in the southern portion of the core, and a relatively small area of anomalous molybdenum occurs near the core’s northern margin. Within the peripheral halo, silver-in-soil values range from 1 ppm Ag to as high as 16.9 ppm Ag, including 12.3 ppm Ag, 12.2 ppm Ag, 11 ppm Ag, 10.2 ppm Ag, 9.8 ppm Ag, while values > 3 ppm Ag are very common. Also, within this halo, lead-in-soil values occur as high as 3310.4 ppb Pb including 957.5 ppm Pb, 832.8 ppb Pb, 748 ppm Pb, 689.1 ppb Pb, with associated zinc-in-soil values as high as 1747 ppb Zn including 1360 ppm Zn, 1137 ppm Zn, 941 ppm Zn, 763 ppm Zn, 729 ppm Zn, and 713 ppm Zn. A limited 2022 prospecting and mapping program included the collection of 19 rock grab samples returning values as high as 1269.2 ppm Cu, 106.02 ppm Mo, 27.265 ppm Ag, 3100.1 ppm Zn, 2624.78 ppm Pb, 378.52 ppm Bi, and two samples returning over-limit values for Li (> 2000 ppm Li). The geochemical zonation seen in soils and supporting hyperspectral analysis of rock samples indicate that the anomaly may represent the surface expression of a copper molybdenum porphyry core surrounded by distal or epithermal style silver-lead-zinc mineralization.
In 2023 two deep-penetrating Induced Polarization – Resistivity survey lines were completed over the Isaac target with a total of eight chargeability anomalies identified. The bismuth soil anomaly appears to be controlled by faults interpreted from the IP resistivity data. The bismuth and copper core of the soil anomaly is underlain by multiple chargeability anomalies which sit above a resistivity low that is interpreted as a fault structure. Lead, zinc, and silver, which form a halo around the core, are coincident with fault structures on the south side and north side of the survey area which trend NE (065°) and NW (290°) respectively. Isaac is a recently recognized (2021) target and has never been drilled tested.
Toonie Property
Soil sampling has defined a zoned anomaly that may be related to a buried intrusion. The distribution of values with an Au-Mo-Cu domain and more distal Zn-Pb and Ag may indicate a porphyry system.
Hyperspectral Analysis & Results
During 2023, crushed coarse rejects from 2022 prospecting rock samples from the Pedlar and Hayes properties were analyzed with an ASD TerraSpec® 4 Hi-Res Mineral Spectrometer. Results were uploaded and processed using IMDEX’s aiSIRIS™ cloud-based mineral interpretation AI software to produce semi-quantitative, standardized mineral interpretations and analytics.
The Hyperspectral analysis results for the prosecting rock samples show alteration mineralogy consistent with a porphyry deposit model.
A total of 17 prospecting rock samples were collected at the Bridget target and 19 samples at the Isaac target. Samples from both the Bridget and Isaac targets show anomalous trace element enrichments, including copper, molybdenum and silver, consistent with proximal porphyry copper-style mineralization. Hyperspectral data for the Isaac target samples provide evidence for phyllic alteration characterized by muscovite and potassic alteration, with evidence of propylitic alteration found only on the southern edge of the sampled area where significant chlorite is observed. The Bridget samples show no evidence of phyllic alteration, however most samples show both geochemical and hyperspectral evidence for widespread propylitic alteration involving epidote, chlorite and albite, as well as minor potassic alteration.
Qualified Person
Steven Walsh, P.Geo. and Senior Geologist for the Company is a “qualified person” as defined under National Instrument 43-101 – Standards of Disclosure of Mineral Projects and has reviewed and approved the content of this news release.
About White Gold Corp.
The Company owns a portfolio of 15,362 quartz claims across 21 properties covering 305,102 hectares (3,051 km2) representing approximately 40% of the Yukon’s emerging White Gold District. The Company’s flagship White Gold project hosts four near-surface gold deposits which collectively contain resource estimate of 1,732,300 ounces of gold in indicated resources (35.2 million tonnes grading 1.53 grams per tonne gold) and 1,265,900 ounces of gold in inferred resources (32.2 million tonnes grading 1.22 g/t Au) (see the Company’s news release dated October 6, 2025)(3)(4). Regional exploration work has also produced several other new discoveries and prospective targets on the Company’s claim packages which border sizable gold discoveries including the Coffee project owned by Fuerte Metals with Measured and Indicated Resources of 80.0.2 Mt grading 1.15 g/t Au for 2.96 million ounces of gold, and Inferred Resources of 21.2 Mt grading 1.17 g/t Au for 0.80 million ounces gold(8)(2)(4), and Western Copper and Gold Corporation’s Casino project which has Measured and Indicated Resources of 2,490.7 Mt grading 0.18 g/t Au, 0.14% Cu for 14.8 million ounces of gold and 7.6 billion pounds of copper, and Inferred Resources of 1,412.5 Mt grading 0.14 g/t Au, 0.10% Cu for 6.3 million ounces of gold and 3.1 billion pounds of copper(1)(2)(4). For more information visit www.whitegoldcorp.ca.
(1) See Western Copper and Gold Corporation technical report titled “Casino project, Form 43-101F1 Technical Report Feasibility Study, Yukon Canada”, Effective Date June 13, 2022, Issue Date August 8, 2022, NI 43-101 Compliant Technical Report prepared by Daniel Roth, PE, P.Eng., Mike Hester, F Aus IMM, John M. Marek, P.E., Laurie M. Tahija, MMSA-QP, Carl Schulze, P.Geo., Daniel Friedman, P.Eng., Scott Weston, P.Geo., available on SEDAR+.
(2) The QP has been unable to verify the information. The information is not necessarily indicative to the mineralization on the properties that are subject of the disclosure.
(4) All numbers are rounded. Overall numbers may not be exact due to rounding.
(5) See December 1, 2025 News Release “Selkirk Copper Announces Initial Drill Results – Successfully Expands Minto North West Zone with a High-Grade Intercept of 5.21% Cu, 0.47 g/t Au, 26.68 g/t Ag over 8.7m within a broader zone of 2.39% Cu, 0.32 g/t Au and 11.61 g/t Ag over 23.4 m in drill hole 25SCM001.
(6) See Cascadia Minerals New Release dated June 9, 2025 “Cascadia Minerals and Granite Creek Copper Announce Merger to Create a Leading Yukon Copper-Gold Exploration and Development Company”.
(7) Allan, M.M., Mortensen, J.K., Hart, C.J.R., Bailey, L.A., Sánchez, M.G., Ciolkiewicz, W., McKenzie, G.G. and Creaser, R.A., 2013, Magmatic and Metallogenic Framework of West-Central Yukon and Eastern Alaska: Society of Economic Geologists, Special Publication 17, pp. 111-168.
(8) See Fuerte Metals press release titled “Fuerte Announces Transformational Acquisition of the Coffee Project from Newmont Corporation” dated September 15, 2025.
Cautionary Note Regarding Forward Looking Information
This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. “Forward-looking information” includes, but is not limited to, statements with respect to the terms, timing and outcome of the Spin-Out; receipt of the required shareholder, regulatory, court and stock exchange approvals in connection with the Spin-Out; listing of SpinCo shares; the anticipated benefits of the Spin-Out; the entering into of the Arrangement Agreement; the formation of SpinCo; the assets to be transferred to SpinCo in connection with the Spin-Out; and anticipated strategic and growth opportunities. Generally, but not always, forward- looking information and statements can be identified by the use of words such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates”, or “believes” or the negative connotation thereof or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved” or the negative connotation thereof. Such forward-looking information and statements are based on numerous assumptions, completion of the Spin-Out, including the ability of the parties to receive, in a timely manner and on satisfactory terms, the necessary regulatory, court and shareholder approvals; the ability of the parties to satisfy, in a timely manner, the other conditions to the completion of the Spin-Out; that the anticipated benefits of the Spin-Out will be realized; that general business and economic conditions will not change in a material adverse manner, that financing will be available if and when needed and on reasonable terms, and that third party contractors, equipment and supplies and governmental and other approvals required to conduct the Company’s planned exploration activities will be available on reasonable terms and in a timely manner. Although the assumptions made by the Company in providing forward-looking information or making forward-looking statements are considered reasonable by management at the time, there can be no assurance that such assumptions will prove to be accurate.
Forward-looking information and statements also involve known and unknown risks and uncertainties and other factors, which may cause actual events or results in future periods to differ materially from any projections of future events or results expressed or implied by such forward-looking information or statements, including, among others: the failure to obtain shareholder, regulatory, court or stock exchange approvals in connection with the Spin-Out; failure to realize the anticipated benefits of the Spin-Out or implement the business plan for SpinCo; the diversion of management time on transaction-related issues; expectations regarding negative operating cash flow and dependence on third party financing, uncertainty of additional financing, no known mineral reserves or resources, reliance on key management and other personnel, potential downturns in economic conditions, actual results of exploration activities being different than anticipated, changes in exploration programs based upon results, and risks generally associated with the mineral exploration industry, environmental risks, changes in laws and regulations, community relations and delays in obtaining governmental or other approval.
Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in the forward-looking information or implied by forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated, estimated or intended. Accordingly, readers should not place undue reliance on forward-looking statements or information. The Company undertakes no obligation to update or reissue forward-looking information as a result of new information or events except as required by applicable securities laws.
Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this news release.
For Further Information, Please Contact:
Contact Information: David D’Onofrio Chief Executive Officer White Gold Corp. (647) 930-1880 ir@whitegoldcorp.ca
VANCOUVER, BC / ACCESS Newswire / February 11, 2026 / North Shore Uranium Ltd. (TSX-V:NSU) (“North Shore” or the “Company“) is pleased to announce that it has entered into an awareness service campaign agreement (the “RSD Agreement“) with Resource Stock Digest (“RSD“), under the terms of which RSD will conduct interviews and generate reports on the Company and will distribute to the RSD existing database.
On February 10, 2026, the Company entered into the RSD Agreement for an eighteen (18) month term, which can be terminated with thirty (30) days’ notice, after a minimum term of three (3) months. Monthly payments of US$2,450 will be paid at the end of each month, with a one-time initiation fee of US$8,500. All fees payable by the Company to RSD, pursuant to the RSD Agreement, will be paid out of general working capital of the Company.
RSD is owned and operated by Nicholas Hodge and Gerardo De Real and headquartered in Round Rock, Texas, USA. The Company and RSD act at arm’s length, and RSD has no present interest, directly or indirectly, in the Company or its securities, or any right or present intent to acquire such an interest, except for Nicholas Hodge owns 700,000 common shares of the Company (“Shares“) and 350,000 share purchase warrants, and Gerardo Del Real owns or controls 500,000 Shares and 250,000 share purchase warrants. There are no performance factors contained in the RSD Agreement and RSD will not receive Shares or stock options as compensation.
The RSD Agreement is subject to approval by the TSX Venture Exchange.
North Shore is currently exploring for uranium at its Rio Puerco project in the Grants Uranium District of New Mexico and its Falcon and West Bear properties at the eastern margin of the Athabasca Basin in Saskatchewan. In addition, the Company continues to evaluate opportunities in the United States and Canada to complement its portfolio of uranium properties.
ON BEHALF OF THE BOARD
Brooke Clements, President, Chief Executive Officer and Director
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
NEW YORK CITY, NY / ACCESS Newswire / February 11, 2026 / Black Titan Corporation (NASDAQ:BTTC):
Executive Summary:
The corporate digital asset sector is witnessing a structural bifurcation between “Passive Accumulators” (e.g., MicroStrategy) and “Active Allocators”. This week, the emergence of compliant, KYC-gated lending pools on Base has provided the necessary infrastructure for the latter group to operationalize balance sheet assets, effectively transforming corporate treasuries into on-chain liquidity providers.
1. The DAT Sector: Black Titan Corp (BTTC) & The “Active Treasury” Pivot
Black Titan Corp (NASDAQ:BTTC): Execution of the DAT+ Framework
Following the successful closure of its $200M convertible note facility, BTTC has commenced the deployment phase of its “Digital Asset Treasury Plus” (DAT+) strategy. Unlike peers that utilize capital solely for asset accumulation, BTTC is executing a “Net Interest Margin” (NIM) strategy.
Strategy Analysis: Market intelligence suggests that when available, BTTC would allocate a portion of stablecoin treasury to capture “DeFi Base Rates” (currently ~8-12% on institutional-grade pools) while its cost of capital on the convertible debt remains significantly lower. This should increase the potential for a positive carry trade previously accessible only to hedge funds.
Peer Comparison: This marks a divergence from the MicroStrategy (MSTR) model. While MSTR focuses on Bitcoin-per-share accretion via passive holding, BTTC is focusing on Yield-per-share accretion via active liquidity provision.
Valuation Impact: We believe the equity markets would value BTTC not just as a beta-proxy to BTC price, but as an operating company based on its projected cash flows derived from on-chain yield generation.
Broader DAT Trends: FASB Adoption
The universal adoption of FASB’s fair value accounting standards (effective for fiscal years beginning after Dec. 15, 2024) is accelerating corporate adoption. We are observing a trend where mid-cap companies are exploring “Tokenized Money Market Funds” (e.g., BlackRock BUIDL) as a cash-equivalent layer, serving as a stepping stone toward the more aggressive “Active DAT” model BTTC intends to follow.
2. Institutional Infrastructure: The Enabling Rails (Base & Morpho)
Base: The Corporate On-Ramp
Coinbase’s L2 network, Base, has effectively consolidated its role as the “regulated distribution layer.” New data from this week indicates a sharp rise in “Coinbase Prime Web3 Wallet” activity interacting with whitelisted smart contracts. This integration allows corporate treasurers to access DeFi applications without managing raw private keys, fulfilling the internal control requirements of public auditors.
Morpho: Scaling “Permissioned Markets”
The Morpho protocol has become the primary venue for Corporate DAT execution due to its modular architecture (Morpho Blue).
Corporate Vaults: We are seeing the proliferation of “Permissioned Vaults” curated by regulated entities (e.g., Steakhouse Financial, Gauntlet). These vaults utilize a whitelist (KYC/KYB) to ensure that corporate liquidity providers like BTTC only interact with compliant counterparties.
Collateral Quality: A key development this week is the increased acceptance of Tokenized U.S. Treasury Bills as collateral within these vaults. This allows DAT issuers to borrow stablecoins against low-volatility RWA collateral, minimizing the liquidation risks associated with volatile assets like ETH or BTC.
Market Interpretation: The “Yield Arbitrage” Thesis
We are witnessing a fundamental shift in how public capital interacts with decentralized finance.
Demand Side (The DATs): Public companies (like BTTC) have access to capital via public equity and debt markets.
Supply Side (The Protocols): DeFi protocols (like Morpho) offer high structural yields due to capital scarcity.
The Synthesis: We believe a new form of arbitrage has emerged. Companies are raising funds in the traditional economy (at ~3-5% cost) and deploying them into the digital economy (at ~8-12% yield). Protocols that can bridge this gap with audit-ready infrastructure – specifically Base (distribution) and Morpho (risk engine) – are capturing the majority of this institutional flow.
Disclaimer
This research note is provided for informational purposes only. It does not constitute an offer to sell or a solicitation of an offer to buy any securities or digital assets. The analysis regarding Black Titan Corp (BTTC) and decentralized protocols involves significant regulatory, technical, and market risks. Past performance of treasury strategies is not indicative of future results.
About Black Titan Corp (NASDAQ:BTTC)
Black Titan Corp is a recent digital asset technology company focusing on the DAT+ strategy, utilizing its corporate balance sheet to support, govern, and provide liquidity to decentralized protocols. For more information, please visit https://www.blacktitancorp.com/ttdat.html.
Experienced kids advertising executive strengthens direct-to-brand strategy as Company provides business update
VANCOUVER, BC / ACCESS Newswire / February 10, 2026 / Kidoz Inc. (TSXV:KDOZ)(OTCQB:KDOZF) (the “Company”), a global AdTech platform delivering safe mobile gamer engagement at scale, today announced the appointment of John Nolie as Vice President of Sales, North America, as part of its continued focus on accelerating direct-to-brand revenue across the region.
Mr. Nolie brings deep experience across advertising, media, entertainment, and technology, with specific category expertise in kids and family privacy and compliance, including COPPA, CARU, CCPA, and GDPR-K. He previously co-founded and led battery POP, a kids-focused digital studio and agency, and has worked extensively across gaming, OTT, influencer, and brand sponsorships. His background includes building long-term brand and agency relationships, delivering compliant, high-impact campaigns for leading advertisers.
Management believes Mr. Nolie’s experience and domain expertise further strengthen Kidoz’s ability to expand direct brand partnerships and capitalize on growing demand for compliant, privacy-first advertising solutions within the kids and family segment.
“Kidoz has been a long-time strategic partner and I’ve had the pleasure of working closely with the team for several years,” said John Nolie, Vice President of Sales, North America at Kidoz Inc. “I’m excited to formally join the organization at a time when privacy-first, COPPA-certified solutions are more critical than ever. With Kidoz’s strong position in the kids and family ecosystem, industry-leading ad technology, and top-tier creative services, I see a significant opportunity to deepen brand partnerships and drive meaningful growth.”
“We are thrilled to welcome John to the Kidoz team,” said Jason Williams, CEO of Kidoz Inc. “As brands increasingly look for scalable, compliant solutions, John’s deep experience in the kids and family market strengthens our ability to accelerate growth in North America and capitalize on the opportunities we see ahead in 2026.”
As part of this appointment, Kidoz also provided a brief update on recent business developments. The Company continues to see strong momentum across its kids-safe advertising platform, supported by increasing regulatory scrutiny, brand safety requirements, and demand for privacy-by-design solutions.
Notably, the same underlying technology that supports Kidoz’s core kids business is also available for privacy-first advertising across broader age segments within mobile gaming via Kidoz Inc.’s non-child network, Prado.
Kidoz recently increased capital markets visibility through participation in the DealFlow Discovery Conference and the release of a CEO interview with Small Cap Discoveries, highlighting the Company’s strategy, privacy-first infrastructure, and positioning ahead of upcoming full-year financial reporting. The Company also continues to see adoption of its Kidoz Privacy Shield, a privacy-by-design advertising infrastructure certified under PRIVO’s FTC-approved COPPA Safe Harbor and awarded the GDPR Kids Privacy Assured Shield, supporting compliant, scalable mobile advertising without reliance on personal identifiers.
Management believes these developments, combined with the appointment of Mr. Nolie, further align the Company’s commercial execution with its strategic focus on compliant growth, trusted brand relationships, and long-term value creation.
For full details of the Company’s operations and financial results, please refer to the Securities and Exchange Commission website at www.sec.gov or the Kidoz Inc. investor website at https://investor.kidoz.net or on the https://www.sedarplus.com website.
About Kidoz Inc.
Kidoz Inc. (TSXV:KDOZ)(OTCQB:KDOZF) (www.kidoz.net) is a global AdTech platform delivering safe mobile gamer engagement at scale.
Originally built to protect kids, the platform also now enables advertisers to reach audiences of all ages across the entire mobile gaming ecosystem, using privacy-first contextual targeting, including the growing segment of users who opt out of personal data tracking.
Its technology stack combines proprietary SDK integrations, the Kidoz Privacy Shield, and the Kite IQ contextual AI engine to deliver compliant, high-impact campaigns aligned with COPPA, GDPR-K, Apple ATT, and global standards. Google-certified and Apple-approved, Kidoz reaches more than a billion users worldwide.
Trusted by leading brands, Kidoz enables advertisers to reach high-value gaming audiences through a unified suite of managed, programmatic, SSP, DSP, and Ad Exchange solutions.
The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for forward-looking statements. Certain information included in this press release (as well as information included in oral statements or other written statements made or to be made by the company) contains statements that are forward-looking, such as statements relating to anticipated future success of the company. Such forward-looking information involves important risks and uncertainties that could significantly affect anticipated results in the future and, accordingly, such results may differ materially from those expressed in any forward-looking statements made by or on behalf of the company. For a description of additional risks and uncertainties, please refer to the company’s filings with the Securities and Exchange Commission. Specifically, readers should read the Company’s Annual Report on Form 20-F, filed with the SEC and the Annual Financial Statements and Management Discussion & Analysis filed on SEDAR on April 24, 2025, and the prospectus filed under Rule 424(b) of the Securities Act on March 9, 2005 and the SB2 filed July 17, 2007, and the TSX Venture Exchange Listing Application for Common Shares filed on June 29, 2015 on SEDAR, for a more thorough discussion of the Company’s financial position and results of operations, together with a detailed discussion of the risk factors involved in an investment in Kidoz Inc.
Refusal to review the submission is inconsistent with feedback at pre-Phase 3 and pre-submission consultations; Moderna has requested a Type A meeting to understand the path forward
mRNA-1010 has been submitted and accepted for review in the EU, Canada and Australia
Company does not expect any impact on its 2026 financial guidance
CAMBRIDGE, MA / ACCESS Newswire / February 10, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced the U.S. Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER) has notified the Company that it will not initiate a review of the biologics license application (BLA) for its investigational influenza vaccine, mRNA-1010, and has issued a Refusal-to-File (RTF) letter. Moderna had exercised a Priority Review Voucher to facilitate a timely review of the application.
CBER’s RTF letter, signed by Center Director Vinayak Prasad, MD, MPH, identified the choice of a licensed standard-dose seasonal influenza vaccine comparator as the sole reason for the refusal to initiate the review of Moderna’s application. Specifically, the letter cited the lack of an “adequate and well-controlled” study with a comparator arm that “does not reflect the best-available standard of care.” Neither the relevant regulation, 21 C.F.R. § 314.126 (Adequate and well-controlled studies), nor the FDA’s guidance for industry on seasonal influenza vaccines contain any reference to the use of a comparator reflecting the “best-available standard of care.” The letter did not identify any specific safety or efficacy concerns regarding mRNA-1010.
The letter is inconsistent with previous written communications from CBER to Moderna. In April 2024, Moderna submitted the Phase 3 study protocol to CBER for review during a pre-Phase 3 consultation. CBER provided written guidance noting that “while we agree it would be acceptable to use a licensed standard dose influenza vaccine as the comparator in your Phase 3 study, we recommend you use a vaccine preferentially recommended for use in older adults by the ACIP (i.e., Fluzone HD, Fluad or Flublok) for participants >65 years of age in the study. Data on comparative efficacy of your vaccine against an influenza vaccine preferentially recommended for use in the >65 years age group may help inform ACIP’s recommendation for the use of your vaccine in the older adult population. If you proceed with using a standard dose influenza vaccine comparator in participants ≥65 years of age, we agree with your plan to include statements in the Informed Consent Form.” CBER did not raise any objections or clinical hold comments about the adequacy of the Phase 3 trial after the submission of the protocol in April 2024 or at any time before the initiation of the study in September 2024.
In August of 2025, following the successful completion of the Phase 3 efficacy trial in which mRNA-1010 met all agreed upon pre-specified primary endpoints, Moderna held a pre-submission meeting with CBER. In its written feedback, CBER requested that supportive analyses on the comparator be included in the submission and indicated that the data would be a “significant issue during review of your BLA.” Moderna provided the additional analyses requested by CBER in its submission, including data from a separate Phase 3 trial (P303 Part C) comparing mRNA-1010 against a licensed high-dose influenza vaccine. At no time in the pre-submission written feedback or meeting did CBER indicate that it would refuse to review the file.
“This decision by CBER, which did not identify any safety or efficacy concerns with our product, does not further our shared goal of enhancing America’s leadership in developing innovative medicines,” said Stéphane Bancel, Chief Executive Officer of Moderna. “It should not be controversial to conduct a comprehensive review of a flu vaccine submission that uses an FDA-approved vaccine as a comparator in a study that was discussed and agreed on with CBER prior to starting. We look forward to engaging with CBER to understand the path forward as quickly as possible so that America’s seniors, and those with underlying conditions, continue to have access to American-made innovations.”
Moderna has requested a Type A meeting with CBER to understand the basis for the RTF letter. In the interest of transparency, the Company has posted the full letter on its website, linked here.
mRNA-1010 has been accepted for review in the EU, Canada and Australia. Submissions in additional countries are planned for 2026. Moderna expects the earliest potential approvals for mRNA-1010 to begin in late 2026 or early 2027, subject to those ongoing regulatory reviews.
The Company does not expect an impact to its 2026 financial guidance based on the RTF from CBER.
About Moderna’s mRNA-1010 Submission
Moderna’s mRNA-1010 BLA submission includes two positive Phase 3 studies that enrolled a total of 43,808 participants and met all pre-specified primary endpoints. Both Phase 3 designs were reviewed by FDA prior to study initiation. P303 Part C was a safety and immunogenicity study that compared mRNA-1010 against a high-dose comparator in adults aged 65 years or older. P304 was a safety and relative efficacy study that compared mRNA-1010 against a licensed standard-dose comparator in adults aged 50 years and older. In both Phase 3 studies, the primary endpoints showed statistical superiority of mRNA-1010 compared with the respective comparators. P303 has been published in a peer-reviewed publication and P304 has been submitted for publication.
The trial design for the P304 efficacy study, showing superiority over a licensed standard-dose influenza vaccine, is similar to that used to approve two licensed influenza vaccines that are preferentially recommended for adults aged 65 years or older in the U.S. Those approved products demonstrated a similar degree of statistically superior relative efficacy over a standard-dose influenza vaccine comparator as was achieved by mRNA-1010 in P304.[1][2] One of these products used the same licensed standard-dose comparator (Fluarix®), which is licensed in the U.S. for all adults, including for adults aged 65 years or older. Approximately 2 million U.S. adults aged 65 years or older received a standard-dose influenza vaccine in the most recent influenza season.[3][4]
Many countries outside the U.S. do not preferentially recommend high-dose influenza vaccines over standard-dose influenza vaccines for adults aged 65 or older.[5]
About Moderna
Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna’s mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more.
With a global team and a unique culture, driven by the company’s values and mindsets, Moderna’s mission is to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn.
Fluarix® is a registered trademark of the GlaxoSmithKline group of companies.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements regarding: the status of Moderna’s pending regulatory submissions for mRNA-1010 in the EU, Canada and Australia; Moderna’s submissions in additional countries planned for 2026; timing for the earliest potential approvals for mRNA-1010, subject to regulatory reviews; Moderna’s requested Type A meeting with CBER; and Moderna’s expectation of no impact on its 2026 financial guidance. In some cases, forward-looking statements can be identified by terminology such as “will,” “may,” “should,” “could,” “expects,” “intends,” “plans,” “aims,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Moderna’s control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These risks, uncertainties, and other factors include, among others, those risks and uncertainties described under the heading “Risk Factors” in Moderna’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the U.S. Securities and Exchange Commission (SEC), and in subsequent filings made by Moderna with the SEC, which are available on the SEC’s website at www.sec.gov. Except as required by law, Moderna disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this press release in the event of new information, future developments or otherwise. These forward-looking statements are based on Moderna’s current expectations and speak only as of the date of this press release.
[5] Ku JH, et al. Comparative Effectiveness of Licensed Influenza Vaccines in Preventing Influenza-related Medical Encounters and Hospitalizations in the 2022-2023 Influenza Season Among Adults ≥65 Years of Age. Clin Infect Dis. 2024 Nov 22;79(5):1283-1292. doi: 10.1093/cid/ciae375.
MCLEAN, VA / ACCESS Newswire / February 10, 2026 / Gladstone Investment Corporation (Nasdaq:GAIN) (the “Company”) today announced that it priced a public offering of $100.0 million aggregate principal amount of 7.125% Notes due 2031 (the “Notes”) on February 10, 2026. The Notes will mature on May 1, 2031 and may be redeemed in whole or in part at any time or from time to time at the Company’s option on or after May 1, 2028. The Notes will bear interest at a rate of 7.125% per year payable quarterly on February 1, May 1, August 1 and November 1 of each year, beginning May 1, 2026. The Company also granted the underwriters a 30-day option to purchase up to an additional $15.0 million in aggregate principal amount of Notes to cover overallotments, if any. The Company expects to list the Notes on the Nasdaq Global Select Market under the trading symbol “GAING” within 30 days of issuance. Oppenheimer & Co. Inc., Lucid Capital Markets, LLC, B. Riley Securities, Inc. and Muriel Siebert & Co., LLC are acting as joint book-running managers for this offering. Clear Street LLC, Huntington Securities, Inc., InspereX LLC, Ladenburg Thalmann & Co. Inc. and Wedbush Securities Inc. are acting as co-managers for this offering.
The closing of the transaction is subject to customary closing conditions and the Notes are expected to be delivered on or about February 18, 2026.
The Company intends to use the net proceeds from this offering to repay a portion of the amount outstanding under its revolving credit facility, to fund new investment opportunities, and for other general corporate purposes.
Investors are advised to carefully consider the investment objectives, risks and charges and expenses of the Company before investing. The preliminary prospectus supplement, dated February 9, 2026, and the accompanying prospectus, dated April 18, 2024, which have been filed with the U.S. Securities and Exchange Commission (the “SEC”), contain this and other information about the Company and should be read carefully before investing.
The offering is being conducted as a public offering under the Company’s effective shelf registration filed with the SEC (File No. 333-277452).
To obtain a copy of the preliminary prospectus supplement for this offering and the accompanying prospectus, please contact: Oppenheimer & Co. Inc., Attention: Syndicate Prospectus Department, 85 Broad Street, 26th Floor, New York, NY 10004, by telephone at (212) 667-8055, or by email at EquityProspectus@opco.com.
This communication shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.
About Gladstone Investment Corporation: Gladstone Investment Corporation is a publicly traded business development company that seeks to make secured debt and equity investments in lower middle market businesses in the United States in connection with acquisitions, changes in control and recapitalizations.
Forward-Looking Statements
This press release contains statements as to the Company’s intentions and expectations of the outcome of future events that are forward-looking statements. You can identify these statements by the fact that they do not relate strictly to historical or current facts. Forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that may cause the actual results to differ materially from those anticipated at the time the forward-looking statements are made. These statements relate to the offering of Notes and the anticipated use of the net proceeds by the Company. No assurance can be given that the transaction discussed above will be completed on the terms described, or at all. Completion of the offering on the terms described, and the application of net proceeds, are subject to numerous conditions, many of which are beyond the control of the Company. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. For a description of certain risks to which the Company is or may be subject, please refer to the factors discussed under the captions “Forward-Looking Statements” and “Risk Factors” included in the Company’s filings with the SEC (accessible at www.sec.gov).
CONTACT: For further information: Gladstone Investment Corporation, 703-287-5893.
HESPERIA, CA / ACCESS Newswire / February 10, 2026 / 5E Advanced Materials, Inc. (“5E” or the “Company”) (Nasdaq:FEAM)(ASX:5EA), a company focused on becoming a vertically integrated global leader and supplier of refined borates and advanced boron derivative materials, today announced it will host its Q2 call on Tuesday, February 17, 2026 at 5:00 p.m. Eastern Time.
The webcast and teleconference will provide an update on the Company’s execution across federal financing engagement, customer validation and commercial discussions, and engineering and pre-FID workstreams, as 5E advances the Fort Cady Project toward a potential Final Investment Decision.
Teleconference Replay (Available until March 3, 2026):
Toll Free: +1 (877) 481-4010
International: +1 (919) 882-2331
Replay Passcode: 53637
About 5E Advanced Materials, Inc.
5E Advanced Materials, Inc. (Nasdaq: FEAM) (ASX:5EA) is focused on becoming a vertically integrated global leader and supplier of refined borates and advanced boron materials, complemented by calcium-based co-products, and potentially other by-products such as lithium carbonate. The Company’s mission is to become a supplier of these critical materials to industries addressing global decarbonization, energy independence, food, national security, and the defense sector. The Company believes factors such as government regulation and incentives focused on domestic manufacturing and supply chains and capital investments across industries will drive demand for end-use applications like solar and wind energy infrastructure, neodymium-ferro-boron magnets, defense applications, lithium-ion batteries, and other critical material applications. The business is based on the Company’s large domestic boron resource, which is located in Southern California and designated as Critical Infrastructure by the U.S. Department of Homeland Security, and boron was included on the U.S. Government’s 2025 Critical Minerals List.
Forward Looking Statements
Statements in this press release may contain “forward-looking statements” that are subject to substantial risks and uncertainties. Forward-looking statements contained in this press release may be identified by the use of words such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential” or “continue” or the negative of these terms or other similar expressions, and include, but are not limited to, statements regarding the Company’s development plans, production capabilities, commercialization strategy, offtake discussions, customer qualification processes and success thereof, market demand for boron and lithium, the potential applications of its products across energy, defense, agriculture and industrial markets, and ability to access and secure any government-based financing. Any forward-looking statements are based on 5E’s current expectations, forecasts, and assumptions and are subject to a number of risks and uncertainties that could cause actual outcomes and results to differ materially and adversely from those set forth in or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, statements regarding the Company’s development plans, production capabilities, commercialization strategy, offtake discussions, customer qualification processes, market demand for boron and lithium, and potential applications of its products across energy, defense, and industrial markets, and ability to access and secure any government-based financing. For a discussion of other risks and uncertainties, and other important factors, any of which could cause our actual results to differ from those contained in the forward-looking statements, see the section entitled “Risk Factors” in 5E’s most recent Annual Report on Form 10-K and its other reports filed with the SEC. Forward-looking statements contained in this announcement are based on information available to 5E as of the date hereof and are made only as of the date of this release. 5E undertakes no obligation to update such information except as required under applicable law. These forward-looking statements should not be relied upon as representing 5E’s views as of any date subsequent to the date of this press release. In light of the foregoing, investors are urged not to rely on any forward-looking statement in reaching any conclusion or making any investment decision about any securities of 5E.
GA-ASI’s YFQ-42A Platform to Support Next-Generation Expeditionary Air Operations
SAN DIEGO, CALIFORNIA / ACCESS Newswire / February 10, 2026 / General Atomics Aeronautical Systems, Inc. (GA-ASI) was competitively selected by the U.S. Marine Corps (USMC) for evaluation in the Marine Air-Ground Task Force Uncrewed Expeditionary Tactical Aircraft (MUX TACAIR) Collaborative Combat Aircraft (CCA) program. The agreement integrates GA-ASI’s expertise in autonomy and uncrewed aircraft systems with a government-provided mission package, usingthe YFQ-42A platform as a surrogate to evaluate integration with crewed fighters.
The contract initiates integration of a Marine Corps mission kit into the YFQ-42A surrogate platform for assessment within the Marine Air Ground Task Force (MAGTF).
The USMC contract includes the rapid development of autonomy for the government-supplied mission kit – a cost-effective, sensor-rich, software-defined suite capable of delivering kinetic and non-kinetic effects – positioning the solution for use in expeditionary operations. This work will support evaluations of future MUX TACAIR capabilities.
“This selection builds upon the GA-ASI autonomous systems in use today and demonstrates our commitment to delivering next generation capabilities for critical USMC missions,” said Mike Atwood, Vice President of Advanced Programs for GA-ASI. “Our FQ-42, combined with our proven autonomy architecture and integration expertise, positions us to rapidly deliver an affordable CCA solution that enhances the Marine Air-Ground Task Force’s operational effectiveness in contested environments.”
GA-ASI was selected by the U.S. Air Force in April 2024 to build production-representative flight test articles for the CCA program. The YFQ-42A successfully conducted its maiden flight in August 2025, validating a “genus/species” concept for rapid, modular, and low-cost uncrewed fighter aircraft development. This approach enables a common core aircraft design that can be rapidly adapted for different mission sets and service requirements.
The YFQ-42A is a purpose-built CCA platform developed as part of GA-ASI’s ongoing investment in next-generation autonomous combat aircraft. The aircraft’s modular design enables rapid integration of mission systems. GA-ASI’s autonomy architecture, demonstrated through multiple live flight tests, provides the foundation for human-machine teaming in complex combat scenarios.
About GA-ASI
General Atomics Aeronautical Systems, Inc., is the world’s foremost builder of Unmanned Aircraft Systems (UAS). Logging more than 9 million flight hours, the Predator® line of UAS has flown for over 30 years and includes MQ-9A Reaper®, MQ-1C Gray Eagle®, MQ-20 Avenger®, and MQ-9B SkyGuardian®/SeaGuardian®. The company is dedicated to providing long-endurance, multi-mission solutions that deliver persistent situational awareness and rapid strike.
Avenger, EagleEye, Gray Eagle, Lynx, Predator, Reaper, SeaGuardian, and SkyGuardian are trademarks of General Atomics Aeronautical Systems, Inc., registered in the United States and/or other countries.
